Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Clinical trial NCT04191187 · COMPLETED

Trial details

NCT number: NCT04191187
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Biphenotypic Acute Leukemia Undifferentiated Leukemia Prolymphocytic Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Myeloproliferative Neoplasm Relapsed Large Cell Lymphoma Mantle Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma

Start date: 2019-12-06
Primary completion: 2024-02-11
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.